A clinico-epidemiological study of melasma
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20184457Keywords:
Epidemiological, Melasma, PregnancyAbstract
Background: Melasma is an acquired increased pigmentation of the skin, characterized by gray-brown symmetrical patches, mostly in the sun-exposed areas of the skin.
Methods: The proposed study is an epidemiological cross sectional study which was carried out in the department of dermatology in a teaching institute from October 2007 to September 2008 at Pramukh Swami Medical College, Karamsad, Gujarat. A total of 60 patients were enrolled for the study over a period of one year.
Results: The main age group affected was 30-39 years i.e. 48.33% patients. 50 patients were females.18 patients had a positive family history of melasma. 12 patients had a positive history of using OC Pills. Malar region was the commonest affected area found in 52 patients followed by Centro-facial in 31 and least involvement was seen in forehead region in 24 patients. 20 patients reported association of occurrence of the lesions with pregnancy, 09 patients reported sunlight to be the offending agent.
Conclusions: Females were affected more commonly during their late third decade of life. Although we did not find the exact cause of melasma, we noticed that sun-exposure, pregnancy, and taking of oral contraceptive pills could precipitate or exacerbate the melasma.
References
Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol. 2009;54:303–92.
Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin. 2007;25:343–522.
Estrada-Castanon R, Torres-Bibiano B, Alarcon-Hernandez H. Epidemiologia cutanea en dos sectores de atencion medica en Guerrero, Mexico. Dermatologia Rev Mex. 1992;36:29–34.
Failmezger C. Incidence of skin disease in Cazco, Peru. Int J Dermatol. 1992;36:29–34.
Goh CL, Dlova CN. A retrospective Study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999;40:455–8.
Katsambas AD, Stratigos AJ, Lotti TM. Melasma. In: Katsambas AD, Lotti TM, editors. European handbook of dermatological treatments. 2nd ed. Springer, Berlin; 2003: 336–341.
Resnik S. Melasma induced by oral contraceptive drug. JAMA. 1967;199:601–5.
Vazquez M, Maldonado H, Benmaman C. Melasma in men, a clinical and histological study. Int J Dermatol. 1988;27:25–7.
Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC., Jr Melasma: A clinical, light microscopic, ultrastructural and immunoflorescence study. J Am Acad Dermatol. 1981;4:698–710.
Pathak MA. Clinical and therapeutic aspects of Melasma: An overview. In: Fitz Patrick TB, Wick MM, Toda K, editors. Brown melanoderma. University of Tokyo Press, Tokyo; 1986: 161–172.
Katasambas A, Antoniou C. Melasma: Classification and treatment. J Eur Acad Dermatol Venereol. 1995;4:217–23.
Thappa DM. Melasma (chloasma): A review with current treatment options. Indian J Dermatol. 2004;49:165–76.
Goh CL, Dlova CN. A retrospective Study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999;40:455–8.
Nicolaidou E, Antoniou C, Katsambas AD. Origin, clinical presentation, and diagnoses of facial hypermelanoses. Dermatol Clin. 2007;25:321–6.
